1978
DOI: 10.1016/s0140-6736(78)91763-4
|View full text |Cite
|
Sign up to set email alerts
|

BRONCHOPULMONARY INFECTION DUE TO Β-Lactamase-Producing BRANHAMELLA CATARRHALIS TREATED WITH AMOXYCILLIN/CLAVULANIC-ACID

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
17
1

Year Published

1979
1979
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(21 citation statements)
references
References 4 publications
2
17
1
Order By: Relevance
“…It has been implicated in a wide variety of infectious processes (G. V. Doern, M. J. Miller, R. E. Winn, submitted for publication), including conjunctivitis, otitis media, sinusitis, endocarditis, meningitis, septicemia, and pneumonia, particularly in patients with underlying compromised pulmonary function. Although previously defined as being uniformly susceptible to penicillin (5), several recent studies demonstrated that clinically significant isolates of B. catarrhalis were resistant to penicillin by virtue of their ability to produce /3-lactamase (8,10,(12)(13)(14). Due to the paucity of reported clinical antibiotic trials and in vitro susceptibility studies, little additional information exists regarding the antimicrobial susceptibility of B. catarrhalis.…”
mentioning
confidence: 99%
“…It has been implicated in a wide variety of infectious processes (G. V. Doern, M. J. Miller, R. E. Winn, submitted for publication), including conjunctivitis, otitis media, sinusitis, endocarditis, meningitis, septicemia, and pneumonia, particularly in patients with underlying compromised pulmonary function. Although previously defined as being uniformly susceptible to penicillin (5), several recent studies demonstrated that clinically significant isolates of B. catarrhalis were resistant to penicillin by virtue of their ability to produce /3-lactamase (8,10,(12)(13)(14). Due to the paucity of reported clinical antibiotic trials and in vitro susceptibility studies, little additional information exists regarding the antimicrobial susceptibility of B. catarrhalis.…”
mentioning
confidence: 99%
“…302). Another report described the successful eradication of beta-lactamase-producing Branhamella catarrhalis from the transtracheal aspirates of three patients with exacerbation of their chronic bronchitis (7).…”
Section: Discussionmentioning
confidence: 99%
“…Clavulanic acid (CA) is a -lactam antibiotic produced by Streptomyces clavuligerus. It is clinically used as a wide-spectrum irreversible -lactamase inhibitor to treat various types of infections [1]. We recently reported a double-reporter guided mutant selection (dRGMS) method to generate CA over-producing mutants of S. clavuligerus [2].…”
mentioning
confidence: 99%